Huadong Medicine Co Ltd (000963) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.90x

Huadong Medicine Co Ltd (000963) has a Cash Flow Reinvestment Rate of 1.90x as of September 2025, reinvesting CN¥297.09 Million (capex CN¥297.09 Million ) from operating cash flow of CN¥155.98 Million. Explore 000963 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.90x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥297.09 Million
Capex + Investments

Operating Cash Flow

CN¥155.98 Million
CNY

Capital Expenditures

CN¥297.09 Million
CNY

Huadong Medicine Co Ltd Cash Flow Reinvestment Rate (1998–2024)

Historical reinvestment intensity for Huadong Medicine Co Ltd across 26 annual periods. Also explore Huadong Medicine Co Ltd total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Huadong Medicine Co Ltd (1998–2024)

Year-by-year capital reinvestment analysis for Huadong Medicine Co Ltd. For live market cap and broader valuation context, see 000963 market cap overview.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 0.47x CN¥1.75 Billion CN¥3.75 Billion CN¥1.73 Billion ▼ -45.3%
2023 0.85x CN¥3.36 Billion CN¥3.93 Billion CN¥1.61 Billion ▼ -5.0%
2022 0.90x CN¥2.14 Billion CN¥2.38 Billion CN¥1.19 Billion ▲ +142.3%
2021 0.37x CN¥1.18 Billion CN¥3.17 Billion CN¥819.10 Million ▼ -39.8%
2020 0.62x CN¥2.10 Billion CN¥3.41 Billion CN¥1.47 Billion ▼ -23.4%
2019 0.80x CN¥1.61 Billion CN¥2.00 Billion CN¥1.35 Billion ▲ +5.4%
2018 0.76x CN¥1.56 Billion CN¥2.04 Billion CN¥876.46 Million ▲ +25.7%
2017 0.61x CN¥1.01 Billion CN¥1.66 Billion CN¥478.69 Million ▲ +32.6%
2016 0.46x CN¥616.70 Million CN¥1.35 Billion CN¥467.00 Million ▼ -64.0%
2015 1.27x CN¥837.59 Million CN¥658.54 Million CN¥383.01 Million ▲ +190.0%
2014 0.44x CN¥324.89 Million CN¥740.85 Million CN¥324.89 Million ▼ -37.7%
2013 0.70x CN¥335.84 Million CN¥476.98 Million CN¥335.84 Million ▲ +76.1%
2012 0.40x CN¥256.97 Million CN¥642.73 Million CN¥256.97 Million ▼ -97.1%
2011 13.91x CN¥224.21 Million CN¥16.12 Million CN¥224.21 Million ▲ +6009.9%
2009 0.23x CN¥129.26 Million CN¥567.94 Million CN¥129.26 Million ▼ -11.1%
2008 0.26x CN¥88.24 Million CN¥344.69 Million CN¥88.24 Million ▲ +110.8%
2007 0.12x CN¥32.27 Million CN¥265.79 Million CN¥32.27 Million ▼ -91.7%
2006 1.46x CN¥83.53 Million CN¥57.38 Million CN¥83.53 Million ▲ +492.0%
2005 0.25x CN¥50.00 Million CN¥203.33 Million CN¥50.00 Million ▼ -95.4%
2004 5.33x CN¥66.60 Million CN¥12.51 Million CN¥66.60 Million ▲ +558.2%
2003 0.81x CN¥73.24 Million CN¥90.54 Million CN¥73.24 Million ▼ -65.7%
2002 2.36x CN¥56.47 Million CN¥23.94 Million CN¥56.47 Million ▲ +386.1%
2001 0.49x CN¥53.21 Million CN¥109.67 Million CN¥53.21 Million ▼ -85.6%
2000 3.37x CN¥66.01 Million CN¥19.59 Million CN¥66.01 Million ▲ +1565.3%
1999 0.20x CN¥11.40 Million CN¥56.32 Million CN¥11.40 Million ▼ -62.1%
1998 0.53x CN¥12.70 Million CN¥23.80 Million CN¥12.70 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow